[Special Stock] SK Biopharm Turns Operating Profit Positive in Q1 This Year... Surges Over 6%

[Asia Economy Reporter Park Jihwan] On the 12th, SK Biopharm's stock price is strong due to improved earnings news.

As of 10:11 AM on the day, SK Biopharm is trading at 113,500 KRW, up 7,000 KRW (6.57%) compared to the previous trading day.

The turnaround to profitability in operating profit for the first quarter is cited as the reason for the stock price strength. SK Biopharm announced through a disclosure on the day that its first-quarter sales reached 140 billion KRW and operating profit was 75.9 billion KRW, representing a 3464% increase in sales and an increase of 129.4 billion KRW in operating profit compared to the same period last year, turning to profitability.